These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30408155)

  • 1. Mesenchymal stem cells gene signature in high-risk myeloma bone marrow linked to suppression of distinct IGFBP2-expressing small adipocytes.
    Mehdi SJ; Johnson SK; Epstein J; Zangari M; Qu P; Hoering A; van Rhee F; Schinke C; Thanendrarajan S; Barlogie B; Davies FE; Morgan GJ; Yaccoby S
    Br J Haematol; 2019 Feb; 184(4):578-593. PubMed ID: 30408155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common and different alterations of bone marrow mesenchymal stromal cells in myelodysplastic syndrome and multiple myeloma.
    Choi H; Kim Y; Kang D; Kwon A; Kim J; Min Kim J; Park SS; Kim YJ; Min CK; Kim M
    Cell Prolif; 2020 May; 53(5):e12819. PubMed ID: 32372504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloma cells shift osteoblastogenesis to adipogenesis by inhibiting the ubiquitin ligase MURF1 in mesenchymal stem cells.
    Liu Z; Liu H; He J; Lin P; Tong Q; Yang J
    Sci Signal; 2020 May; 13(633):. PubMed ID: 32457115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone Marrow Adipocytes Promote the Survival of Multiple Myeloma Cells and Up-Regulate Their Chemoresistance].
    Wei XQ; Zhang YM; Sun Y; Ling HY; He YN; Fu JX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):154-161. PubMed ID: 36765493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells.
    Guo J; Zhao Y; Fei C; Zhao S; Zheng Q; Su J; Wu D; Li X; Chang C
    Cell Death Dis; 2018 May; 9(5):512. PubMed ID: 29724992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment.
    Battula VL; Chen Y; Cabreira Mda G; Ruvolo V; Wang Z; Ma W; Konoplev S; Shpall E; Lyons K; Strunk D; Bueso-Ramos C; Davis RE; Konopleva M; Andreeff M
    Blood; 2013 Jul; 122(3):357-66. PubMed ID: 23741006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAZ downregulated ANXA1 expression to modulate myeloma cell interactions with bone marrow mesenchymal stromal cells.
    Abegunde SO; Grieve S; Reiman T
    Exp Hematol; 2024 Oct; 138():104282. PubMed ID: 39032857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of the bone marrow MSC population in a xenograft model of early multiple myeloma.
    Berlier JL; Rethnam M; Banu Binte Abdul Majeed A; Suda T
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1175-1181. PubMed ID: 30553454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Pattern of Mesenchymal Stem Cell Expression Is an Independent Marker of Outcome in Multiple Myeloma.
    Schinke C; Qu P; Mehdi SJ; Hoering A; Epstein J; Johnson SK; van Rhee F; Zangari M; Thanendrarajan S; Barlogie B; Davies FE; Yaccoby S; Morgan GJ
    Clin Cancer Res; 2018 Jun; 24(12):2913-2919. PubMed ID: 29563136
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple Myeloma Cells Alter Adipogenesis, Increase Senescence-Related and Inflammatory Gene Transcript Expression, and Alter Metabolism in Preadipocytes.
    Fairfield H; Costa S; Falank C; Farrell M; Murphy CS; D'Amico A; Driscoll H; Reagan MR
    Front Oncol; 2020; 10():584683. PubMed ID: 33680918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein malnutrition induces bone marrow mesenchymal stem cells commitment to adipogenic differentiation leading to hematopoietic failure.
    Cunha MC; Lima Fda S; Vinolo MA; Hastreiter A; Curi R; Borelli P; Fock RA
    PLoS One; 2013; 8(3):e58872. PubMed ID: 23516566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cell abnormalities in patients with multiple myeloma.
    Garderet L; Mazurier C; Chapel A; Ernou I; Boutin L; Holy X; Gorin NC; Lopez M; Doucet C; Lataillade JJ
    Leuk Lymphoma; 2007 Oct; 48(10):2032-41. PubMed ID: 17917971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow adipocytes is a new player in supporting myeloma cells proliferation and survival in myeloma microenvironment.
    Wei X; Zhang Y; Wang Z; He Y; Ju S; Fu J
    Transl Oncol; 2024 Feb; 40():101856. PubMed ID: 38134840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between mesenchymal stem cells, adipocytes, and osteoblasts in a 3D tri-culture model of hyperglycemic conditions in the bone marrow microenvironment.
    Rinker TE; Hammoudi TM; Kemp ML; Lu H; Temenoff JS
    Integr Biol (Camb); 2014 Mar; 6(3):324-37. PubMed ID: 24463781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalks between integrin alpha 5 and IGF2/IGFBP2 signalling trigger human bone marrow-derived mesenchymal stromal osteogenic differentiation.
    Hamidouche Z; Fromigué O; Ringe J; Häupl T; Marie PJ
    BMC Cell Biol; 2010 Jun; 11():44. PubMed ID: 20573191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt and BMP signaling pathways co-operatively induce the differentiation of multiple myeloma mesenchymal stem cells into osteoblasts by upregulating EMX2.
    Wei XF; Chen QL; Fu Y; Zhang QK
    J Cell Biochem; 2019 Apr; 120(4):6515-6527. PubMed ID: 30450775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phytocannabinoids promote viability and functional adipogenesis of bone marrow-derived mesenchymal stem cells through different molecular targets.
    Fellous T; De Maio F; Kalkan H; Carannante B; Boccella S; Petrosino S; Maione S; Di Marzo V; Iannotti FA
    Biochem Pharmacol; 2020 May; 175():113859. PubMed ID: 32061773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imprinting of Mesenchymal Stromal Cell Transcriptome Persists even after Treatment in Patients with Multiple Myeloma.
    Lemaitre L; DoSouto Ferreira L; Joubert MV; Avet-Loiseau H; Martinet L; Corre J; Couderc B
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32481768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease.
    Garcia-Gomez A; De Las Rivas J; Ocio EM; Díaz-Rodríguez E; Montero JC; Martín M; Blanco JF; Sanchez-Guijo FM; Pandiella A; San Miguel JF; Garayoa M
    Oncotarget; 2014 Sep; 5(18):8284-305. PubMed ID: 25268740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.